Pay in 4 interest-free payments of $6.43 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Whether weight loss continues, and how much, tends to track with the dose you ultimately reach, your starting weight, plus how consistent you are with nutrition, movement, and adherence
Other types of adverse reactions have been defined as: continuing (type C), delayed (type D), end-of-use (type E), failure of therapy (type F) or genetic/genomic (type G)
This pharmacological profile creates a dose-dependent weight loss curve that, in clinical trials, reached 24.2% at the 12mg weekly dose over 48 weeks and an astonishing 28.7% at 12mg over 68 weeks in the TRIUMPH-4 phase 3 trial
doi:10.1038/nature04209
US$ 24.24
US$ 20.31
US$ 26.73
US$ 26.44
US$ 23.48
